PEPTiPEN NAD+
Nicotinamide Adenine Dinucleotide · Pharmaceutical Grade
Pharmaceutical-grade NAD+ (Nicotinamide Adenine Dinucleotide) in a precision auto-injector. Supplied for in vitro and preclinical research use only.
50 in stock
PEPTiPEN NAD+ supplies pharmaceutical-grade nicotinamide adenine dinucleotide for in vitro and preclinical research applications. NAD+ is a coenzyme studied extensively in cellular metabolism research.
Cellular Coenzyme Research
NAD+ is studied as a master co-enzyme in cellular metabolism research. Published literature indicates NAD+ levels decline with age in cellular models. Research applications include investigation of sirtuin, PARP, and CD38 pathways in preclinical settings.
- Investigated for mitochondrial function and ATP production in cell models
- Studied in DNA repair research via PARP enzyme pathway
- Examined in sirtuin longevity pathway research
- Subject of cognitive and neurological preclinical research
- Studied in recovery and inflammation research models
Active Compound
NAD+ (Nicotinamide Adenine Dinucleotide) - pharmaceutical grade, lyophilised. 500mg per cartridge. For research use only.
Delivery System
Precision auto-injector research pen with micro-dose control. For in vitro and preclinical research use only. Not approved for human or veterinary administration.
Research Use Only Disclaimer: This product is intended solely for in vitro research and preclinical study purposes. It is not approved, licensed, or intended for use in humans or animals. The information provided is derived from published scientific literature and is presented for research context only. It does not constitute medical advice. Consult a qualified healthcare professional before any administration involving biological systems.